We’ve developed a tool that combines market sizing predictions, which is then searchable by industry and region. Additionally, we take those sizes in aggregate to help find a consensus estimate from the crowds.
You can read our post on the best way to use a tool like this.
Step 1 was getting patent data into our platform. In our latest release, you can see what direction a company might be heading based on patent topics
Or you can see in aggregate how many patents have been filed about a topic and who the big players are.
You can read more about the patent analytics tool here.
For expert intelligence clients who want to see some of these tools in use, we mapped out what companies are saying about the cardiovascular and diabetes markets, the approximate sizes for both, and what the patent trends look. See it here.
Making more predictions
I made fun of blockchain stuff a bit last week, but a project caught my eye this weekend. Augur has been building a decentralized prediction marketplace (sort of like a betting platform for anything). A company called MedCredits is using Augur to publicly state its goals and stake some ether on the fact that it’s going to hit it.
The Hippocrates dApp is the first decentralized medical app to be deployed within the MedCredits Health System and must meet the following 5 objective criteria by October 15th, 2018:
Hippocrates contracts deployed on Ethereum Mainnet
Smart contracts guide the patient and physician encounter
Patient medical records are encrypted and stored on IPFS
ETH is a payment option within the Hippocrates dApp
Doctors are available to diagnose and provide medical recommendations to patients
If the above criteria are met by the above date, then MedCredits will have successfully launched the Hippocrates dApp. Reporters on Augur should use the above criteria to verify this outcome.
A couple of thoughts come to mind while reading this. An early stage company trying to guess and stick to its roadmap three months out is ambitious, especially since it’s a healthcare company with so much potentially outside of its control (regulations, for one).
But the part of this that interests me is the ability to incentivize potential partners to work with early stage blockchain projects. “Death by pilot” is a pretty common phenomenon where institutions will partner with startups and then the project sort of just…slowly dies out. However if a partnering company is actually tied to a date of completion with associated goals AND gets a payout if that happens, that could potentially solve for this issue.
Institutions (and the people in them) having skin in the game for pilots is an important part of their success, otherwise no one in the institution is a champion for the startup internally.
I have no idea if this “decentralized medical platform” is going to work at all, but this incentive system is intriguing and worth watching. And props to the company for being transparent about its roadmap.